Targeting the Mycobacterium ulcerans cytochrome bc 1 :aa 3 for the treatment of Buruli ulcer
Mycobacterium ulcerans is the causative agent of Buruli ulcer (BU). Existing anti-tubercular drugs have been used to treat the condition with varying success. Here, the authors show that a clinical-stage drug candidate for tuberculosis, Q203, is effective at killing M. ulcerans and is a promising th...
Guardado en:
Autores principales: | Nicole Scherr, Raphael Bieri, Sangeeta S. Thomas, Aurélie Chauffour, Nitin Pal Kalia, Paul Schneide, Marie-Thérèse Ruf, Araceli Lamelas, Malathy S. S. Manimekalai, Gerhard Grüber, Norihisa Ishii, Koichi Suzuki, Marcel Tanner, Garrett C. Moraski, Marvin J. Miller, Matthias Witschel, Vincent Jarlier, Gerd Pluschke, Kevin Pethe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ead11814b4ee465d85398bdcb2064c81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital.
por: Helen R Please, et al.
Publicado: (2021) -
Understanding the transmission of Mycobacterium ulcerans: A step towards controlling Buruli ulcer.
por: Anthony J Muleta, et al.
Publicado: (2021) -
A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans
por: Dezemon Zingue, et al.
Publicado: (2018) -
The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
por: Yang Liu, et al.
Publicado: (2019) -
Amoebae as potential environmental hosts for Mycobacterium ulcerans and other mycobacteria, but doubtful actors in Buruli ulcer epidemiology.
por: Sophie Gryseels, et al.
Publicado: (2012)